QSR 820 (21 CFR PART 820) 法规三

[Code of Federal Regulations]
[Title 21, Volume 8]
[Revised as of April 1, 2008]
[CITE: 21CFR820]
TITLE 21--FOOD AND DRUGS
CHAPTER I--FOOD AND DRUG ADMINISTRATION
DEPARTMENT OF HEALTH AND HUMAN SERVICES
SUBCHAPTER H--MEDICAL DEVICES
PART 820
QUALITY SYSTEM REGULATION
Subpart A--General Provisions
Sec. 820.1 Scope.
(a)Applicability. (1) Current good manufacturing practice (CGMP)
requirements are set forth in this quality system regulation. The
requirements in this part govern the methods used in, and the facilities
and controls used for, the design, manufacture, packaging, labeling,
storage, installation, and servicing of all finished devices intended
for human use. The requirements in this part are intended to ensure that
finished devices will be safe and effective and otherwise in compliance
with the Federal Food, Drug, and Cosmetic Act (the act). This part
establishes basic requirements applicable to manufacturers of finished
medical devices. If a manufacturer engages in only some operations
subject to the requirements in this part, and not in others, that
manufacturer need only comply with those requirements applicable to the
operations in which it is engaged. With respect to class I devices,
design controls apply only to those devices listed in 820.30(a)(2). This
regulation does not apply to manufacturers of components or parts of
finished devices, but such manufacturers are encouraged to use
appropriate provisions of this regulation as guidance. Manufacturers of
human blood and blood components are not subject to this part, but are
subject to part 606 of this chapter. Manufacturers of human cells,
tissues, and cellular and tissue-based products (HCT/Ps), as defined in
1271.3(d) of this chapter, that are medical devices (subject to
premarket review or notification, or exempt from notification, under an
application submitted under the device provisions of the act or under a
biological product license application under section 351 of the Public
Health Service Act) are subject to this part and are also subject to the
donor-eligibility procedures set forth in part 1271 subpart C of this
chapter and applicable current good tissue practice procedures in part
1271 subpart D of this chapter. In the event of a conflict between
applicable regulations in part 1271 and in other parts of this chapter,
the regulation specifically applicable to the device in question shall
supersede the more general.
(2) The provisions of this part shall be applicable to any finished
device as defined in this part, intended for human use, that is
manufactured, imported, or offered for import in any State or Territory
of the United States, the District of Columbia, or the Commonwealth of
Puerto Rico.
(3) In this regulation the term "where appropriate" is used several
times. When a requirement is qualified by "where appropriate," it is
deemed to be "appropriate" unless the manufacturer can document
justification otherwise. A requirement is "appropriate" if
nonimplementation could reasonably be expected to result in the product
not meeting its specified requirements or the manufacturer not being
able to carry out any necessary corrective action.
(b) The quality system regulation in this part supplements
regulations in other parts of this chapter except where explicitly
stated otherwise. In the event of a conflict between applicable
regulations in this part and in other parts of this chapter, the
regulations specifically applicable to the device in question shall
supersede any other generally applicable requirements.
(c)Authority. Part 820 is established and issued under authority of
sections 501, 502, 510, 513, 514, 515, 518, 519, 520, 522, 701, 704,
801, 803 of the act (21 U.S.C. 351, 352, 360, 360c, 360d, 360e, 360h,
360i, 360j, 360l, 371, 374, 381, 383). The failure to comply with any
applicable provision in this part renders a device adulterated under
section 501(h) of the act. Such a device, as well as any person
responsible for the failure to comply, is subject to regulatory action.
(d)Foreign manufacturers. If a manufacturer who offers devices for
import into the United States refuses to permit or allow the completion
of a Food and Drug Administration (FDA) inspection of the foreign
facility for the purpose of determining compliance with this part, it
shall appear for purposes of section 801(a) of the act, that the methods
used in, and the facilities and controls used for, the design,
manufacture, packaging, labeling, storage, installation, or servicing of
any devices produced at such facility that are offered for import into
the United States do not conform to the requirements of section 520(f)
of the act and this part and that the devices manufactured at that
facility are adulterated under section 501(h) of the act.
(e)Exemptions or variances . (1) Any person who wishes to petition
for an exemption or variance from any device quality system requirement
is subject to the requirements of section 520(f)(2) of the act.
Petitions for an exemption or variance shall be submitted according to
the procedures set forth in 10.30 of this chapter, the FDA's
administrative procedures. Guidance is available from the Center for
Devices and Radiological Health, Division of Small Manufacturers,
International and Consumer Assistance (HFZ-220), 1350 Piccard Dr.,
Rockville, MD 20850, U.S.A., telephone 1-800-638-2041 or 240-276-3150,
FAX 240-276-3151.
(2) FDA may initiate and grant a variance from any device quality
system requirement when the agency determines that such variance is in
the best interest of the public health. Such variance will remain in
effect only so long as there remains a public health need for the device
and the device would not likely be made sufficiently available without
the variance.
[61 FR 52654, Oct. 7, 1996, as amended at 65 FR 17136, Mar. 31, 2000;
65 FR 66636, Nov. 7, 2000; 69 FR 29829, May 25, 2005; 72 FR 17399, Apr.
9, 2007]
Sec. 820.3 Definitions.
(a)Act means the Federal Food, Drug, and Cosmetic Act, as amended
(secs. 201-903, 52 Stat. 1040et seq., as amended (21 U.S.C. 321-394)).
All definitions in section 201 of the act shall apply to the regulations
in this part.
(b)Complaint means any written, electronic, or oral communication
that alleges deficiencies related to the identity, quality, durability,
reliability, safety, effectiveness, or performance of a device after it
is released for distribution.
(c)Component means any raw material, substance, piece, part,
software, firmware, labeling, or assembly which is intended to be
included as part of the finished, packaged, and labeled device.
(d)Control number means any distinctive symbols, such as a
distinctive combination of letters or numbers, or both, from which the
history of the manufacturing, packaging, labeling, and distribution of a
unit, lot, or batch of finished devices can be determined.
(e)Design history file (DHF ) means a compilation of records which describes the design history of a finished device.
(f)Design input means the physical and performance requirements of a device that are used as a basis for device design.
(g)Design output means the results of a design effort at each design
phase and at the end of the total design effort. The finished design
output is the basis for the device master record. The total finished
design output consists of the device, its packaging and labeling, and
the device master record.
(h)Design review means a documented, comprehensive, systematic
examination of a design to evaluate the adequacy of the design
requirements, to evaluate the capability of the design to meet these
requirements, and to identify problems.
(i)Device history record (DHR ) means a compilation of records containing the production history of a finished device.
(j)Device master record (DMR ) means a compilation of records
containing the procedures and specifications for a finished device.
(k)Establish means define, document (in writing or electronically), and implement.
(l)Finished device means any device or accessory to any device that
is suitable for use or capable of functioning, whether or not it is
packaged, labeled, or sterilized.
(m)Lot or batch means one or more components or finished devices that
consist of a single type, model, class, size, composition, or software
version that are manufactured under essentially the same conditions and
that are intended to have uniform characteristics and quality within
specified limits.
(n)Management with executive responsibility means those senior
employees of a manufacturer who have the authority to establish or make
changes to the manufacturer's quality policy and quality system.
(o)Manufacturer means any person who designs, manufactures,
fabricates, assembles, or processes a finished device. Manufacturer
includes but is not limited to those who perform the functions of
contract sterilization, installation, relabeling, remanufacturing,
repacking, or specification development, and initial distributors of
foreign entities performing these functions.
(p)Manufacturing material means any material or substance used in or
used to facilitate the manufacturing process, a concomitant constituent,
or a byproduct constituent produced during the manufacturing process,
which is present in or on the finished device as a residue or impurity
not by design or intent of the manufacturer.
(q)Nonconformity means the nonfulfillment of a specified requirement.
(r)Product means components, manufacturing materials, in- process devices, finished devices, and returned devices.
(s)Quality means the totality of features and characteristics that
bear on the ability of a device to satisfy fitness-for-use, including
safety and performance.
(t)Quality audit means a systematic, independent examination of a
manufacturer's quality system that is performed at defined intervals and
at sufficient frequency to determine whether both quality system
activities and the results of such activities comply with quality system
procedures, that these procedures are implemented effectively, and that
these procedures are suitable to achieve quality system objectives.
(u)Quality policy means the overall intentions and direction of an
organization with respect to quality, as established by management with
executive responsibility.
(v)Quality system means the organizational structure,
responsibilities, procedures, processes, and resources for implementing
quality management.
(w)Remanufacturer means any person who processes, conditions,
renovates, repackages, restores, or does any other act to a finished
device that significantly changes the finished device's performance or
safety specifications, or intended use.
(x)Rework means action taken on a nonconforming product so that it
will fulfill the specified DMR requirements before it is released for
distribution.
(y)Specification means any requirement with which a product, process, service, or other activity must conform.
(z)Validation means confirmation by examination and provision of
objective evidence that the particular requirements for a specific
intended use can be consistently fulfilled.
(1)Process validation means establishing by objective evidence that a
process consistently produces a result or product meeting its
predetermined specifications.
(2)Design validation means establishing by objective evidence that
device specifications conform with user needs and intended use(s).
(aa)Verification means confirmation by examination and provision of
objective evidence that specified requirements have been fulfilled.
Sec. 820.5 Quality system.
Each manufacturer shall establish and maintain a quality system that
is appropriate for the specific medical device(s) designed or
manufactured, and that meets the requirements of this part.
Subpart B--Quality System Requirements
Sec. 820.20 Management responsibility.
(a)Quality policy. Management with executive responsibility shall
establish its policy and objectives for, and commitment to, quality.
Management with executive responsibility shall ensure that the quality
policy is understood, implemented, and maintained at all levels of the
organization.
(b)Organization. Each manufacturer shall establish and maintain an
adequate organizational structure to ensure that devices are designed
and produced in accordance with the requirements of this part.
(1)Responsibility and authority. Each manufacturer shall establish
the appropriate responsibility, authority, and interrelation of all
personnel who manage, perform, and assess work affecting quality, and
provide the independence and authority necessary to perform these tasks.
(2)Resources. Each manufacturer shall provide adequate resources,
including the assignment of trained personnel, for management,
performance of work, and assessment activities, including internal
quality audits, to meet the requirements of this part.
(3)Management representative. Management with executive
responsibility shall appoint, and document such appointment of, a member
of management who, irrespective of other responsibilities, shall have
established authority over and responsibility for:
(i) Ensuring that quality system requirements are effectively
established and effectively maintained in accordance with this part; and
(ii) Reporting on the performance of the quality system to management with executive responsibility for review.
(c)Management review. Management with executive responsibility shall
review the suitability and effectiveness of the quality system at
defined intervals and with sufficient frequency according to established
procedures to ensure that the quality system satisfies the requirements
of this part and the manufacturer's established quality policy and
objectives. The dates and results of quality system reviews shall be
documented.
(d)Quality planning. Each manufacturer shall establish a quality plan
which defines the quality practices, resources, and activities relevant
to devices that are designed and manufactured. The manufacturer shall
establish how the requirements for quality will be met.
(e)Quality system procedures. Each manufacturer shall establish
quality system procedures and instructions. An outline of the structure
of the documentation used in the quality system shall be established
where appropriate.
Sec. 820.22 Quality audit.
Each manufacturer shall establish procedures for quality audits and
conduct such audits to assure that the quality system is in compliance
with the established quality system requirements and to determine the
effectiveness of the quality system. Quality audits shall be conducted
by individuals who do not have direct responsibility for the matters
being audited. Corrective action(s), including a reaudit of deficient
matters, shall be taken when necessary. A report of the results of each
quality audit, and reaudit(s) where taken, shall be made and such
reports shall be reviewed by management having responsibility for the
matters audited. The dates and results of quality audits and reaudits
shall be documented.


下一篇:QSR 820 (21 CFR PART 820) 法规二
常用查询
评审进度查询 | 医疗器械标准目录库 | 临床试验机构目录库 | 检测中心承检目录库
医疗器械分类目录 | 医疗器械检测中心受检目录 | 国产必赢亚娱乐官网查询 | 进口必赢亚娱乐官网查询
专家解读
- 1欧盟第四版临床评价,您准备好了吗?
已经拿了CE证书的企业,看过来!2016年6月,欧盟委员会发布了有关临...
- 2FDA新规影响可重复使用的33类医疗器
6月9日,FDA发布一则通告,对特定可重复使用的医疗器械的再处理使用...
- 3警惕医疗器械App造成的产品召回
《医疗器械召回管理办法》(国家食品药品监督管理总局令第29号)已...
- 4【最新汇编】CFDA医疗器械退审数据
实时关注与了解医疗器械行业最新退审资讯,奥咨达为您梳理了2014年...
- 5医疗器械临床试验项目管理
项目管理贯穿医疗器械临床试验的整个过程,如何在有限的资源下,达...
更多>>行业信息
- 欧盟第四版临床评价,您准备好了吗?
- 已经拿了CE证书的企业,看过来!2016年6月,欧盟委员会发布了有关临床评价的更新引导文件MEDD...
- 最高法/检通过药品医械注册造假入刑司法说明!
- 各大检测中心免费检测汇总(持续更新中...)
- 2018年,医疗市场将现19个大变局!
- 医疗器械证照联办、一址多证的时代来临
- CFDA公布“放管服”改革涉及的规范性文件清理结果,2
- 发改委政策发力 6大类医械将获重点支撑
- 【重磅推出】药品医疗器械审评审批改革文件数据库正
- 『大开眼界』国产彩超再获突破,首款语音识别超声系统
- 费森尤斯首家中国独立血液透析中心开业
- 13部委发文:1000亿市场规模大爆发!这类医疗器械真的
